AWS HPC Blog
Author: Ryo Kunimoto
Head of Research DX Group 1, Research Innovation Planning Department: Broadly involved in bio- and cheminformatics research for drug discovery and research environment construction.
How Daiichi Sankyo modernized drug discovery using AWS Parallel Computing Service
This blog was co-authored by Takehiro Nakajima and Mark Azadpour from AWS and Rintaro Yamada, Rei Kajitani and Ryo Kunimoto from Daiichi Sankyo In recent years, the informatics field of drug discovery has seen a rapid increase in workloads requiring large-scale parallel computing, such as genome analysis, structure prediction, and drug design. Daiichi Sankyo has […]